The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 24, 2020

Filed:

Aug. 22, 2013
Applicant:

Tearscience, Inc., Morrisville, NC (US);

Inventors:

Donald R. Korb, Boston, MA (US);

Steve Bacich, Half Moon Bay, CA (US);

Caroline Blackie, North Andover, MA (US);

Stephen M. Grenon, Durham, NC (US);

Assignee:

Johnson & Johnson Vision Care, Inc., Jacksonville, FL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 9/007 (2006.01); A61B 17/32 (2006.01); A61B 90/00 (2016.01);
U.S. Cl.
CPC ...
A61F 9/00718 (2013.01); A61B 17/32002 (2013.01); A61B 2017/320008 (2013.01); A61B 2017/320012 (2013.01); A61B 2090/0817 (2016.02);
Abstract

Methods and apparatuses are disclosed for the diagnosis and removal of the devitalized and/or dead cell material formed in the lid margin to attempt to restore a normal lid margin. In this manner, the devitalized and/or dead cell material are removed or the amount present is reduced or no longer present to prevent, reduce, or affect the transport of lipid secreted by the meibomian glands to the tear film to reduce evaporative dry eye and improve dry eye conditions in patients. The diagnosis and removal of devitalized and/or dead cell material may be performed at desired intervals. Patients that suffer from conditions that block meibomian gland orifices, partial, infrequent, or inhibited blinking resulting in reduced lipid secretions from meibomian glands, and/or blockages in meibomian gland channels reducing secretion of lipids through the meibomian gland orifices may require more frequent diagnosis and treatment to remove devitalized and/or dead cell material.


Find Patent Forward Citations

Loading…